|Last Price$32.50||Day Change (%)-2.43%|
|Open Price$33.39||Day Change ($)-0.81|
|Day Range32.50–33.49||52-Week Range26.25–36.40|
As of Tue 12/1/2015 5:02:00 PM | USD
Enanta Announces New Data on VIEKIRA PAK® (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Patients with Chronic Hepatitis C Virus Infection With or Without Compensated Cirrhosis
Arrowhead Presents Data Showing Robust Sustained Anti-viral Effects with ARC-520 in Hepatitis B Infected Chimpanzees
Though midstream energy's shifting fundamentals challenge Boardwalk, these same changes create opportunities for the majority of pipeline operators we cover.
Marsico Capital CEO Tom Marsico favors the growth prospects of these biotech companies that are producing novel drugs for unmet medical needs.